DNA methylation alterations across time and space in paediatric brain tumours

Abstract DNA methylation is increasingly used for tumour classification and has expanded upon the > 100 currently known brain tumour entities. A correct diagnosis is the basis for suitable treatment for patients with brain tumours, which is the leading cause of cancer-related death in children. D...

Full description

Bibliographic Details
Main Authors: Anna Wenger, Sandra Ferreyra Vega, Elizabeth Schepke, Maja Löfgren, Thomas Olsson Bontell, Magnus Tisell, Daniel Nilsson, Teresia Kling, Helena Carén
Format: Article
Language:English
Published: BMC 2022-07-01
Series:Acta Neuropathologica Communications
Subjects:
Online Access:https://doi.org/10.1186/s40478-022-01406-8
_version_ 1828541658676854784
author Anna Wenger
Sandra Ferreyra Vega
Elizabeth Schepke
Maja Löfgren
Thomas Olsson Bontell
Magnus Tisell
Daniel Nilsson
Teresia Kling
Helena Carén
author_facet Anna Wenger
Sandra Ferreyra Vega
Elizabeth Schepke
Maja Löfgren
Thomas Olsson Bontell
Magnus Tisell
Daniel Nilsson
Teresia Kling
Helena Carén
author_sort Anna Wenger
collection DOAJ
description Abstract DNA methylation is increasingly used for tumour classification and has expanded upon the > 100 currently known brain tumour entities. A correct diagnosis is the basis for suitable treatment for patients with brain tumours, which is the leading cause of cancer-related death in children. DNA methylation profiling is required for diagnosis of certain tumours, and used clinically for paediatric brain tumours in several countries. We therefore evaluated if the methylation-based classification is robust in different locations of the same tumour, and determined how the methylation pattern changed over time to relapse. We sampled 3–7 spatially separated biopsies per patient, and collected samples from paired primary and relapse brain tumours from children. Altogether, 121 samples from 46 paediatric patients with brain tumours were profiled with EPIC methylation arrays. The methylation-based classification was mainly homogeneous for all included tumour types that were successfully classified, which is promising for clinical diagnostics. There were indications of multiple subclasses within tumours and switches in the relapse setting, but not confirmed as the classification scores were below the threshold. Site-specific methylation alterations did occur within the tumours and varied significantly between tumour types for the temporal samples, and as a trend in spatial samples. More alterations were present in high-grade tumours compared to low-grade, and significantly more alterations with longer relapse times. The alterations in the spatial and temporal samples were significantly depleted in CpG islands, exons and transcription start sites, while enriched in OpenSea and regions not affiliated with a gene, suggesting a random location of the alterations in less conserved regions. In conclusion, more DNA methylation changes accumulated over time and more alterations occurred in high-grade tumours. The alterations mainly occurred in regions without gene affiliation, and did not affect the methylation-based classification, which largely remained homogeneous in paediatric brain tumours.
first_indexed 2024-12-12T01:43:04Z
format Article
id doaj.art-314bf8a820aa4c669a7178991cf1a55a
institution Directory Open Access Journal
issn 2051-5960
language English
last_indexed 2024-12-12T01:43:04Z
publishDate 2022-07-01
publisher BMC
record_format Article
series Acta Neuropathologica Communications
spelling doaj.art-314bf8a820aa4c669a7178991cf1a55a2022-12-22T00:42:38ZengBMCActa Neuropathologica Communications2051-59602022-07-0110111410.1186/s40478-022-01406-8DNA methylation alterations across time and space in paediatric brain tumoursAnna Wenger0Sandra Ferreyra Vega1Elizabeth Schepke2Maja Löfgren3Thomas Olsson Bontell4Magnus Tisell5Daniel Nilsson6Teresia Kling7Helena Carén8Sahlgrenska Center for Cancer Research, Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of GothenburgSahlgrenska Center for Cancer Research, Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of GothenburgSahlgrenska Center for Cancer Research, Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of GothenburgSahlgrenska Center for Cancer Research, Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of GothenburgDepartment of Physiology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of GothenburgDepartment of Neurosurgery, Sahlgrenska University HospitalDepartment of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of GothenburgSahlgrenska Center for Cancer Research, Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of GothenburgSahlgrenska Center for Cancer Research, Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of GothenburgAbstract DNA methylation is increasingly used for tumour classification and has expanded upon the > 100 currently known brain tumour entities. A correct diagnosis is the basis for suitable treatment for patients with brain tumours, which is the leading cause of cancer-related death in children. DNA methylation profiling is required for diagnosis of certain tumours, and used clinically for paediatric brain tumours in several countries. We therefore evaluated if the methylation-based classification is robust in different locations of the same tumour, and determined how the methylation pattern changed over time to relapse. We sampled 3–7 spatially separated biopsies per patient, and collected samples from paired primary and relapse brain tumours from children. Altogether, 121 samples from 46 paediatric patients with brain tumours were profiled with EPIC methylation arrays. The methylation-based classification was mainly homogeneous for all included tumour types that were successfully classified, which is promising for clinical diagnostics. There were indications of multiple subclasses within tumours and switches in the relapse setting, but not confirmed as the classification scores were below the threshold. Site-specific methylation alterations did occur within the tumours and varied significantly between tumour types for the temporal samples, and as a trend in spatial samples. More alterations were present in high-grade tumours compared to low-grade, and significantly more alterations with longer relapse times. The alterations in the spatial and temporal samples were significantly depleted in CpG islands, exons and transcription start sites, while enriched in OpenSea and regions not affiliated with a gene, suggesting a random location of the alterations in less conserved regions. In conclusion, more DNA methylation changes accumulated over time and more alterations occurred in high-grade tumours. The alterations mainly occurred in regions without gene affiliation, and did not affect the methylation-based classification, which largely remained homogeneous in paediatric brain tumours.https://doi.org/10.1186/s40478-022-01406-8Childhood cancerDNA methylationBrain tumourEPIC methylation arrayHeterogeneityIntratumour
spellingShingle Anna Wenger
Sandra Ferreyra Vega
Elizabeth Schepke
Maja Löfgren
Thomas Olsson Bontell
Magnus Tisell
Daniel Nilsson
Teresia Kling
Helena Carén
DNA methylation alterations across time and space in paediatric brain tumours
Acta Neuropathologica Communications
Childhood cancer
DNA methylation
Brain tumour
EPIC methylation array
Heterogeneity
Intratumour
title DNA methylation alterations across time and space in paediatric brain tumours
title_full DNA methylation alterations across time and space in paediatric brain tumours
title_fullStr DNA methylation alterations across time and space in paediatric brain tumours
title_full_unstemmed DNA methylation alterations across time and space in paediatric brain tumours
title_short DNA methylation alterations across time and space in paediatric brain tumours
title_sort dna methylation alterations across time and space in paediatric brain tumours
topic Childhood cancer
DNA methylation
Brain tumour
EPIC methylation array
Heterogeneity
Intratumour
url https://doi.org/10.1186/s40478-022-01406-8
work_keys_str_mv AT annawenger dnamethylationalterationsacrosstimeandspaceinpaediatricbraintumours
AT sandraferreyravega dnamethylationalterationsacrosstimeandspaceinpaediatricbraintumours
AT elizabethschepke dnamethylationalterationsacrosstimeandspaceinpaediatricbraintumours
AT majalofgren dnamethylationalterationsacrosstimeandspaceinpaediatricbraintumours
AT thomasolssonbontell dnamethylationalterationsacrosstimeandspaceinpaediatricbraintumours
AT magnustisell dnamethylationalterationsacrosstimeandspaceinpaediatricbraintumours
AT danielnilsson dnamethylationalterationsacrosstimeandspaceinpaediatricbraintumours
AT teresiakling dnamethylationalterationsacrosstimeandspaceinpaediatricbraintumours
AT helenacaren dnamethylationalterationsacrosstimeandspaceinpaediatricbraintumours